You are here: Industry Insights > Sanofi

News List

Sanofi, MedImmune in RSV Alliance contractpharma
March 06, 2017
MedImmune to lead development, AstraZeneca retains manufacturing activities, Sanofi-Pasteur will lead commercialization
Sanofi and Lonza to build €270m mammalian cell culture facility in Switzerland pharmaceutical-technology
March 02, 2017
Sanofi and Lonza have plans to invest €270m in a new mammalian cell culture facility in Visp, Switzerland, for monoclonal antibody production.
Boehringer Ingelheim and Sanofi close business swap in India expressbpd
March 02, 2017
Globally, both companies will become leaders in two different sectors of the pharmaceutical market
Sanofi and Lonza to build €270m mammalian cell culture facility in Switzerland pharmaceutical-technology
March 01, 2017
Sanofi and Lonza have plans to invest €270m in a new mammalian cell culture facility in Visp, Switzerland, for monoclonal antibody production.
Lawmakers decry Army’s planned Zika vaccine license to Sanofi fiercepharma
February 24, 2017
After some nonprofit organizations made noise about the U.S. Army’s plans to license a Zika vaccine to Sanofi, several lawmakers are chiming in to say it’s a bad idea.
Ipsen to Acquire a Portfolio of Select Consumer Healthcare Products from Sanofi americanpharmaceuticalreview
February 15, 2017
Ipsen has entered into a definitive agreement to acquire from Sanofi five consumer healthcare products in certain European territories.
Sanofi agrees to sell five OTC products to Ipsen following deal with Boehringer Ingelheim firstwordpharma
February 14, 2017
Sanofi agreed to sell five consumer healthcare products in certain European territories to Ipsen for 83 million euros ($88 million) in cash, Ipsen announced Monday.
US appeals court allows Sanofi, Regeneron to continue selling PCSK9 inhibitor Praluent firstwordpharma
February 10, 2017
Sanofi and Regeneron Pharmaceuticals announced that the US Court of Appeals for the Federal Circuit suspended a permanent injunction on Praluent (alirocumab) pending the companies' appeal.
Sanofi's fourth-quarter profit more than doubles; Genzyme sales jump firstwordpharma
February 09, 2017
Sanofi announced Wednesday that fourth-quarter net income more than doubled versus the prior year to 790 million euros ($841 million), while sales increased 3.3 percent to 8.9 billion euros ($9.5 billion), meeting analyst estimates.
Sanofi and Immunext Enter Into Agreement to Develop Treatments for Autoimmune Diseases americanpharmaceuticalreview
January 16, 2017
Sanofi and ImmuNext, Inc., have announced an agreement focused on the development of a novel antibody with the potential to treat a range of autoimmune diseases including Lupus and Multiple Sclerosis. Under the terms of the agreement, ImmuNext will grant

Previous page 1 2 3 4 5 6 7 8 9 10 ... 43 44 Next page